ENTITY
Telix Pharmaceuticals

Telix Pharmaceuticals (TLX AU)

88
Analysis
Health Care • Australia
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
more
bullish•Telix Pharmaceuticals
•11 Jul 2024 16:55

Quiddity Leaderboard ASX Sep 24 Rebal: Altium to Trigger Two Intra-Review Replacements in July

The LONGs (intra-review ADD candidates TLX, SFR, ZIP, & CDA) have now outperformed the SHORT (ASX 200) by +4.8% since the beginning of July. Based...

Share
•29 Jun 2024 00:22

Reiterating Japan Overweight -- Add Exposure; Nikkei 225, TOPIX, TOPIX Small All Breaking Out

Reiterating Japan Overweight; $Nikkei 225, $TOPIX, TOPIX Small, $DXJ All Breaking Out with 2+ year RS uptrends intact on Nikkei and TOPIX. Still...

Logo
468 Views
Share
bearish•Tamboran Resources
•21 Jun 2024 06:00

Tamboran Resources US Offering - Strong Recent Momentum but CDIs Have Been Volatile Since Listing

Tamboran Resources (TBN AU) is looking to raise US$175m from listing its shares in the US. In this note, we talk about the deal dynamics and the...

Logo
599 Views
Share
bullish•Telix Pharmaceuticals
•19 Jun 2024 21:30

Telix Pharmaceuticals (TLX AU): Nasdaq IPO Plan Dropped; Future Growth Prospect Remains Intact

​Telix Pharmaceuticals withdraws US IPO due to unfavorable market condition, but remains confident in meeting op. expenses through internal cash....

Logo
466 Views
Share
bullish•Alibaba
•17 Jun 2024 07:45

ECM Weekly (17th June 2024)-Shift Up, Webtoon, Quantum, Guzman, MaoGeping, Johor Plant, Telix, Atour

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
337 Views
Share
x